MECP2 p.Pro492Ser
c.1474C>T · rs267608636 · VCV143477
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2179 | likely benign |
|---|---|---|
| REVEL | 0.438 | indeterminate |
| SaProt | LLR -6.14 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 9.5 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 1.55 | unconstrained · MANE · 1,052 bp · p 2.6e-22 · regional, not allelic |
| Overall | ||
| CADD | 19.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P480S vs ClinVar P492S) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0021% | 47,620 |
| South Asiangrpmax | 0.00176% | 56,725 |
| European (non-Finnish) | 0.000112% | 895,111 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MECP2
- Protein
- p.Pro492Ser
- Coding
- c.1474C>T
- MANE Select
- NM_001110792
- dbSNP
- rs267608636
- Type
- single nucleotide variant
- Location
- chrX:154030390 (GRCh38)
- Structure
- AlphaFold pLDDT 57.25 · 11 PDB
- Residue 480 UniProt numbering
- a UniProt-annotated variant site (in rtt); the 'disordered' region; a UniProt-annotated variant site (in)
Disease context
severe neonatal-onset encephalopathy with microcephaly — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Rett syndrome
For MECP2-related severe neonatal encephalopathy (Orphanet):
- Inheritance
- X-linked recessive
- Onset
- Infancy, Neonatal
Similar variants
- MECP2 p.Pro492= Likely benign ★★ same residue
- MECP2 p.Pro492Leu Uncertain significance ★ same residue
- MECP2 c.414-3C>G Pathogenic ★★★ same condition
- MECP2 c.62+1G>A Pathogenic ★★★ same condition
- MECP2 c.62+2T>G Pathogenic ★★★ same condition
- MECP2 p.Ala143Asp Pathogenic ★★★ same condition
- MECP2 p.Ala291Val Likely pathogenic ★★★ ⚠ same condition
- MECP2 p.Arg127His Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mecp2-p-pro492ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown